Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBaylor Scott & White Health Plan Prior Auth List |…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBaylor Scott & White Health PlanPolicy N/A

    Commercial Prior Authorization / Notification List (partial)

    Customize your policy alerts

    Sign up for all Baylor Scott & White Health Plan policy alerts

    Know when Baylor Scott & White Health Plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs the commercial prior authorization and notification requirements for Baylor Scott & White Health Plan provider network; affects providers submitting preauthorization or notifications for services to plan members.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyCommercial Prior Authorization / Notification List (partial)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionSubmit electronic preauthorization requests via the secure provider portal and verify member benefits prior to providing listed services.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+codes listed (approx.)
    70+genomic/molecular tests
    7/1/2025future effective dates
    NCapplicable state

    Coverage Criteria and Code Listings

    General coverage statements

    General coverage considerations and verification requirements

    Prior authorization is required for services listed on the Commercial Prior Authorization/Notification List and is an approval process to determine medical necessity before providing certain services; prior authorization is not a guarantee of benefits or payment at the time of service.
    Reimbursement of authorized services is dependent upon member eligibility, benefit limitations/exclusions, and plan-specific benefit provisions; always verify benefits by consulting the member benefit booklet or contacting customer service.
    Registered users must submit electronic preauthorization requests via the Baylor Scott & White Health Plan secure provider portal; call the number on the member ID card for portal access or assistance or contact Provider Relations for additional help.
    Notifications (non-authorization notices) are requested for certain services to assist with discharge planning, care coordination, and case management; all services must be medically necessary and appropriate.
    Newly published/assigned codes and new or emerging therapies or technologies not listed may still require prior authorization; check with Baylor Scott & White Health Plan before providing such services.

    Codes and submission instructions

    Listed CPT codes requiring prior authorization or notification (partial list in this extract)

    See the code listings in this document for specific CPT/T/ U codes and effective dates; effective dates are shown alongside each code in the list.
    Submit electronic preauthorization requests via the Baylor Scott & White Health Plan secure provider portal; call the number on the member ID card for portal access or assistance.
    Providers must reference the listed codes and associated effective dates when determining whether a prior authorization or notification is required for a service.

    Code-based authorization/notification stance

    Codes listed are subject to prior authorization/notification per the commercial policy.

    Codes enumerated in the prior authorization/notification list (including surgical, spinal, arthroplasty, injection, imaging, and laboratory/genomic codes) are subject to the plan's prior authorization or notification processes as indicated by the list entries and effective dates.
    Inclusion of a code on the list indicates that prior authorization or notification is required in accordance with the payer's procedures; verify applicable effective dates for each code.

    Coverage stance for listed codes

    This segment does not include clinical coverage criteria; it provides code listings and mapping notes used for prior authorization/notification workflows.

    The excerpt provides code listings, mapped equivalents, descriptive titles, and effective or mapping dates to support prior authorization/notification workflows but does not contain clinical medical necessity criteria in this extract.

    Procedure code requirement entries (partial)

    This fragment is an itemized list of CPT procedure codes with dates; it indicates which procedures require prior authorization or notification but does not include clinical criteria in this excerpt.

    Example code entries from the list (partial): 43210, 43775, 58541, 61863, 62321 — each code entry in the list is paired with an effective/requirement date indicating when the prior authorization/notification requirement applies.
    Dates shown next to each CPT code indicate the effective date for the prior authorization/notification requirement; providers should use these dates to determine applicability.

    Authorization requirement listing (partial)

    Codes in this list are subject to the plan's prior authorization or notification processes as indicated in the broader policy document.

    Injection and implant-related procedure codes (for example, interlaminar epidural injections 62321–62327 and intrathecal/epidural catheter/pump procedures 62350–62362) are listed with effective dates and require prior authorization or notification per the list.
    Spine decompression, laminectomy/laminotomy and related instrumentation and neurostimulation procedure codes (for example 63001–63048, 63650, 63685) are included on the list and are subject to the payer's authorization/notification requirements.

    Prior authorization/notification coverage stance for listed imaging CPT codes

    Codes listed in this section require prior authorization or notification as part of the commercial prior authorization/notification policy; effective dates are shown alongside mappings.

    Imaging CPT codes (CT and MRI for head/brain, spine, extremity, abdomen/pelvis, and cardiac MRI codes such as 70450, 70551, 72141, 73702, 75559) are listed with mapping notes and effective dates and require prior authorization/notification as indicated.
    Providers should consult the specific code entries and their effective dates in the imaging section to determine whether prior authorization or notification is required for a given imaging service.

    Listed procedure codes

    Codes included on the prior authorization/notification list in this excerpt (selected examples shown).

    Radiation oncology and medical physics codes (examples: 77336, 77338, 77370, 77402, 77407, 77412) appear on the list and are subject to prior authorization/notification per the listed entries and dates.
    Diagnostic nuclear medicine and radiopharmaceutical imaging CPT codes (examples: 78071, 78430, 78315, 78709, 78800 series) are included on the list with effective dates and require prior authorization/notification as indicated.

    Coverage listing (partial)

    Codes and panel descriptions included in the commercial prior authorization/notification list (partial extract).

    Imaging nuclear medicine/PET/SPECT codes and descriptors (for example 78709, 78811, 78816) are listed with effective dates and require prior authorization/notification as annotated.
    Genetic testing and genomic panel codes (for example single-gene tests 81161–81167 and multi-gene panels 81443–81451–81455) are listed with descriptors and minimum gene/ panel size guidance where provided; many entries include effective or revision dates.

    Code listing and descriptors

    This excerpt enumerates codes that require prior authorization or notification and provides short descriptions and effective/revision dates.

    Selected genomic panels and molecular pathology codes (e.g., 81445, 81451, 81455, and 81503–81519 series) are present with descriptions of panel scope (gene counts, DNA/RNA analysis) and effective dates; many require prior authorization per the list.
    Category I/III and PLA laboratory codes (examples: 0001U, 0011M, 0010U) are included with service descriptions and effective dates and are subject to the payer's authorization/notification processes.

    Listed services (partial)

    This excerpt enumerates tests/procedures with their descriptions and effective dates; it functions as a list of services that require payer notification or prior authorization per the broader policy.

    Multiple U-codes and M/PLA codes that describe specialized molecular, infectious disease, transplant, and oncology assays (for example 0008U, 0010U, 0037U, 0087U) are listed with descriptions and effective dates and are included on the prior authorization/notification list.
    Providers ordering advanced molecular tests must reference the code list entry and effective date to determine whether prior authorization or notification is required prior to testing.

    Exempt: listing entries (no decision criteria in this window)

    Entries include service/test name, short description, and an associated effective date.

    Representative U/T code examples (for oncology, reproductive medicine, infectious disease, rare disease, and other specialty uses) are provided with short descriptions and effective dates (for example 0120U, 0121U, 0247U, 0250U, 0253U, 0260U).
    These U/T code entries function as informational list items indicating the service/test and the date the prior authorization/notification requirement became effective; clinical coverage criteria are elsewhere in the full policy.

    Code entries (informational)

    Entries specify service/test, clinical area, specimen type, brief method, and effective date.

    Selected U-code entries (examples: 0247U IBP4/SHBG for preterm birth risk, 0250U targeted genomic analysis of 505 genes, 0306U patient-specific MRD panels) include the clinical area, specimen type or method, and effective date in the list.
    Providers should use the listed service descriptions and effective dates to determine if prior authorization or notification is required for these laboratory and diagnostic services.

    Excerpt — code listing without criteria

    Codes and short descriptors with effective dates are provided; no explicit coverage criteria or medical necessity rules are present in this excerpt.

    Representative T- and U-code entries (examples: 0334U, 0335T, 0338T/0339T, 0340U, 0342T) are listed with descriptors and effective dates; these entries indicate the payer requires authorization/notification but do not provide clinical decision criteria in this excerpt.
    When clinical medical necessity criteria are required, providers must refer to the full policy or contact the plan for the applicable documentation requirements supporting an authorization request.

    Partial code list (part 14)

    Partial code list entries with descriptors and effective dates. Coverage stance and criteria are specified elsewhere in the full policy.

    Examples of temporary (T) codes for emerging procedures (for example 0441T–0445T) are included with descriptors and effective dates and are subject to the payer's prior authorization/notification processes as listed.
    Some entries cross-reference alternative descriptors or related codes; providers should reference the list entry and effective date when preparing authorization submissions.

    Code inclusion (part list)

    Codes listed that require prior authorization or notification per payer policy (listed with descriptors and effective dates).

    Additional examples of T-codes (e.g., 0546T, 0552T, 0565T, 0566T, 0633T–0635T, 0680T–0685T) are provided with descriptors and effective dates and are included on the prior authorization/notification list.
    Providers must check the code entry and effective date to determine whether to request prior authorization or submit a notification for these services; effective dates determine applicability of the requirement.

    Code Tables and Coding Details

    Selected procedural CPT codes (partial list)CPTCovered
    00170Anesthesia for intraoral procedures, including biopsy; not otherwise specified
    11950-11954Subcutaneous injection of filling material (eg, collagen) — various volumes
    14041-14302Adjacent tissue transfer/rearrangement and additions
    Breast and graft procedures (partial list)CPTCovered
    19300-19396Breast surgery and reconstruction related CPTs
    20930-20938Graft/allograft/autograft codes (spine-related examples)
    Spine intervention codes (partial list)CPTCovered
    22510-22515Percutaneous vertebroplasty/vertebral augmentation (kyphoplasty) and related
    22526-22527Intradiscal electrothermal annuloplasty
    22600-22632Spinal arthrodesis and interbody techniques
    Orthopedic/spine procedure codesCPT | mixed
    22552-22634, 22800-22867, 22899Various arthrodesis and spinal instrumentation/interbody device CPT codes listed with effective dates.
    23410-23474Shoulder/rotator cuff and arthroplasty CPT codes listed with effective dates.
    27125-27138, 27332-27446, 27486Hip and knee arthroplasty and related CPT codes (including injection procedures) listed with effective dates.
    29805-29871Arthroscopy CPT codes (shoulder/hip/knee) listed with effective dates.
    Example CPT code mappingsCPT
    29828Tenodesis (listed among arthroscopy/knee codes)
    29860Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty) mapped to arthroscopy, hip, diagnostic
    31660Bronchoscopy with bronchial thermoplasty mapping present later in segment
    Sample CPT codes from this fragmentCPTCovered
    43210Esophagogastroduodenoscopy, flexible, transoral; with esophagogastric fundoplasty, partial or complete
    43775Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (sleeve gastrectomy)
    58541Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
    Epidural/interlaminar injection codesCPT
    62321Injection, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance
    62322Injection, interlaminar epidural or subarachnoid, lumbar or sacral; without imaging guidance
    62323Injection, interlaminar epidural or subarachnoid, lumbar or sacral; with imaging guidance
    Neurostimulation and related injection codesCPT
    63650Percutaneous implantation of neurostimulator electrode array, epidural
    63685Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural
    64454Genicular nerve injections with imaging guidance (when performed)
    Imaging CPT codesCPT
    70450CT, head or brain; without contrast
    70551MRI brain without contrast
    70553MRI brain with contrast / sequences
    Selected brain and spine MRI codesCPT
    70551Magnetic resonance imaging, brain; without contrast
    70553Magnetic resonance imaging, brain; with contrast
    72141MR spinal canal and contents, cervical; without contrast
    72148MR spinal canal and contents, lumbar; without contrast
    Breast MRI codesCPT
    77048Magnetic resonance imaging, breast, without contrast material; bilateral
    77049Magnetic resonance imaging, breast, without contrast material; bilateral (with contrast mapping shown)
    Radiation therapy/physics (examples)CPT
    77334Radiation treatment planning, other (listed)
    77336Continuing medical physics consultation, reported per week
    77338MLC device(s) for IMRT, design and construction
    Proton therapy and brachytherapy (examples)CPT
    77520Proton treatment delivery; simple
    77522Proton treatment delivery; simple, with compensation
    77767Remote afterloading HDR radionuclide skin surface brachytherapy (lesion up to 2.0 cm)
    Diagnostic nuclear medicine (examples)CPT
    78012Thyroid uptake
    78071Parathyroid planar imaging (including subtraction); with tomographic (SPECT)
    78430Myocardial imaging, PET perfusion study with CT transmission scan
    Nuclear medicine / PET / SPECT imaging codesCPTCovered
    78709Kidney imaging morphology; with vascular flow and function, single/multiple studies with pharmacological intervention
    78811PET imaging; limited area
    78816PET whole body
    Single-gene and targeted genetic testsCPTCovered
    81161DMD deletion/duplication analysis
    81162BRCA1/BRCA2 full sequence and duplication/deletion analysis
    81220CFTR common variants
    Genomic panels and large-scale testingCPTCovered
    81445Solid organ neoplasm genomic panel, 5-50 genes
    81455Solid organ or hematolymphoid neoplasm panel, 51+ genes
    81416Exome sequence analysis (comparator exome listed separately)
    Selected genomic and PLA codesmixedCovered
    81451Hematolymphoid neoplasm genomic sequence analysis panel, 5-50 genes; RNA analysis
    81455Solid organ or hematolymphoid neoplasm genomic sequence analysis panel, >=51 genes; DNA or combined DNA/RNA analysis
    81456Solid organ or hematolymphoid neoplasm genomic sequence analysis panel, >=51 genes; RNA analysis
    0001URed blood cell antigen typing, DNA, 35 antigens from 11 blood groups
    0011MOncology, prostate cancer, mRNA expression assay of 12 genes, RT-PCR from plasma/urine
    Selected U-codesmixed
    0010UInfectious disease (bacterial), strain typing by whole genome sequencing, phylogenetic-based report of strain relatedness, per submitted isolate
    0037UTargeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis of 324 genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
    0087UCardiology (heart transplant), mRNA gene expression profiling by microarray of 1,283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a probability score
    Representative U/T codes and descriptions from listingmixed
    0120UOncology (B-cell lymphoma classification) mRNA gene expression profiling (58 genes) from FFPE; algorithm reports likelihood for PMBCL and DLBCL with COO subtyping
    0121UOncology (colon cancer) targeted KRAS/NRAS analysis (codons 12,13,61) from FFPE
    0129UOncology (colon cancer) targeted KRAS/NRAS analysis = Hereditary breast cancer-related disorders genomic sequence and del/dup panel
    0141UFungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique
    0153UOncology (breast), mRNA gene expression profiling by NGS of 101 genes from FFPE; reports triple negative subtype and immune cell involvement
    0172UOncology (solid tumor), somatic BRCA1/2 and homologous recombination deficiency analysis, FFPE
    0211UOncology (pan-tumor), DNA and RNA by NGS from FFPE; report SNVs, CNAs, TMB, MSI, therapy association
    0239UTargeted genomic sequence panel, solid tumor, cell-free DNA, 311+ genes
    0244UOncology (solid organ), comprehensive genomic profiling, 257 genes, FFPE
    0243UObstetrics (preeclampsia), placental-growth factor assay with predictive algorithm
    1–10 of 14
    1/2
    Selected T-codes in this sectionCPT
    0274TPercutaneous laminotomy/laminectomy (interlaminar approach) for decompression; any method
    0335TInsertion of sinus tarsi implant
    0338TTranscatheter renal sympathetic denervation, unilateral
    0339TTranscatheter renal sympathetic denervation, bilateral
    Selected U-codes (molecular/diagnostic assays)HCPCS
    0247UObstetrics (preterm birth) IBP4/SHBG predictive-risk stratification
    0250UOncology targeted genomic sequence DNA analysis of 505 genes
    0306UOncology (MRD) NGS initial patient-specific panel from cfDNA
    0340UOncology (pan-cancer) personalized MRD from plasma
    Representative codes from excerptmixed
    0334UOncology targeted genomic sequence analysis (84+ genes) — FFPE tumor tissue
    0335TInsertion of sinus tarsi implant
    0391UOncology NGS 437 genes — FFPE tissue with immunotherapy response score
    0444UOncology targeted genomic sequence analysis panel of 361 genes — FFPE tumor tissue
    T-codes examplesCPT
    0441TAblation, percutaneous, cryoablation, includes imaging guidance; upper extremity distal/peripheral nerve
    0442TAblation, percutaneous, cryoablation; nerve plexus or other truncal nerve (eg, brachial plexus, pudendal)
    0443TAblation, percutaneous, cryoablation; includes imaging guidance; (alternate descriptor present)
    U-codes oncology/genomic examplesmixed
    0485UOncology (solid tumor), cell-free DNA and RNA by NGS, interpretative report
    0495UOncology (prostate), circulating plasma proteins w/ polygenic risk score algorithm
    Examples of T-codes listedCPT
    0546TRadiofrequency spectroscopy, real time, intraoperative margin assessment, at the time of partial mastectomy, with report
    0552TLow-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professional
    0559TAnatomic model 3D-printed from image data set(s); first individually prepared and processed component
    Additional T-codes (examples)CPT
    0633TComputed tomography, breast, including 3D rendering, when performed, unilateral; without contrast material
    0650TProgramming device evaluation (remote) of subcutaneous cardiac rhythm monitor system, with iterative adjustment and report
    0674TLaparoscopic insertion of new or replacement of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function
    Volume / area thresholds referenced in codes
    Subcutaneous filler volume tiers11950 = 1 cc or less; 11951 = 1.1–5.0 cc; 11952 = 5.1–10.0 cc; 11954 = over 10.0 cc
    Adjacent tissue transfer area thresholds14041 = defect 10.1–30.0 sq cm; 14301 = defect 30.1–60.0 sq cm; 14302 = each additional 30.0 sq cm (or part) — list separately
    Skin graft area thresholds15100 = first 100 sq cm or less (trunk/arms/legs or 1% body area for infants/children); 15101 = each additional 100 sq cm (or part) — list separately
    Full-thickness graft donor site size15200 = trunk free graft, 20 sq cm or less
    Effective / requirement dates (overview)
    Policy-level effective dateCommercial Prior Authorization/Notification List — Effective May 01, 2026
    Code-specific effective dates presentMany CPT/U/T entries include an 'Effective Date' or date pair (e.g., 00170 Effective Date = 1/2/2020; 11950 Effective Date = 1/2/2020; 43210 1/2/2020 = 4/1/2021)
    Imaging and procedure mapping datesNumerous imaging and procedure codes show mapping/effective dates (examples in chunks 54, 72, 109) used to determine when PA/notification applied
    Providers must reference dates for applicabilityEffective dates should be used to determine whether the prior authorization/notification requirement applied at time of service
    Panel gene count thresholds
    Small-to-moderate panel range81445 / 81450 / 81451 — genomic sequence analysis panels specified as 5–50 genes
    Large panel threshold (51+ genes)81455 / 81456 — panels described as 51 or greater genes (>=51 genes) for solid organ or hematolymphoid neoplasms
    Minimum gene counts for select panels81443 example requires sequencing of at least 15 genes for certain severe inherited-condition panels; other listings cite minimums such as 60 genes for specific indications (see chunk 141/146)
    Gene panel size threshold examples
    Examples of large panel gene counts0250U = targeted genomic DNA analysis of 505 genes; 0334U = targeted genomic sequence analysis, 84+ genes; 0253U = RNA expression panel, 238 genes
    Representative multi-gene panel sizes0334U (84+ genes), 0250U (505 genes), 0253U (238 genes) appear as examples of panels spanning 50–505+ genes
    Panel descriptors indicate gene-count rangesMany U-codes/0334U/0250U entries list exact gene counts or '84 or more', '505 genes' etc., used to classify panel size
    Effective date examples (code-level)
    Common effective dates cited in the listExamples include 1/1/2023 (many genomic/U-codes), 7/1/2025 (future effective dates for several panels), 10/1/2018 and 1/2/2020 for older mappings
    U/T-code implementation datesSelected U/T entries show provider-effective dates (e.g., 0334U, 0335T = 1/1/2023; 0414U = 7/1/2025)
    Imaging/radiation datesRadiation and imaging codes often include 10/1/2021, 8/1/2018, 9/1/2018 among effective dates (see chunks 109, 92, 126)

    Provider Instructions and Required Actions

    Prior Authorization

    Prior authorization and submission

    Prior authorization is required for services and codes listed on this prior authorization/notification list. Providers must submit electronic preauthorization requests via the Baylor Scott & White Health Plan secure provider portal (call the number on the member’s ID card for portal access). Note that prior authorization is not a guarantee of payment; reimbursement depends on member eligibility, benefit limitations/exclusions, and plan-specific benefits.

    • Submit requests through the secure provider portal; contact Provider Relations for assistance.
    • Authorization does not guarantee payment; verify member benefits via the benefit booklet or customer service.
    Documentation Required

    Notification requests

    The plan requests notifications for certain services to support discharge planning, care coordination, and case management. Providers should submit requested notifications per the payer’s instructions to enable care coordination activities.

    • Notifications are separate from prior authorization and are used for care coordination and discharge planning.
    • Follow the payer’s notification process as listed on the provider portal or contact customer service for instructions.
    Prior Authorization

    Spine arthrodesis and related procedures

    Spine arthrodesis and related spinal fusion/interbody instrumentation procedures listed on the prior authorization/notification list require provider submission per the payer’s process; codes and effective dates are shown in the list (examples include 22552, 22554, 22556, 22558, 22600, 22612, 22614, 22630, 22632).

    • These procedures are included on the commercial prior authorization/notification list and have effective dates noted.
    • Reference the code list when requesting authorization or submitting notifications.
    Prior Authorization

    Shoulder and interbody device procedures

    Shoulder procedures and interbody device/instrumentation codes (examples: 23410–23473 series; interbody insertion codes 22853–22858) are on the prior authorization/notification list and require preauthorization/notification per the payer’s submission process.

    • Shoulder repair and arthroplasty CPTs (eg, 23410, 23412, 23430, 23470, 23472) have effective dates shown.
    • Insertion of interbody biomechanical devices (eg, 22853, 22854, 22856–22858) is listed with effective dates and requires authorization.
    Prior Authorization

    Hip and knee arthroplasty and injections

    Hip and knee arthroplasty procedures and related injection procedures (examples: 27125–27138, 27332, 27428–27446, 27486, and arthroscopy/arthroplasty codes 29860–29883 series) are included on the list and require prior authorization or notification as shown alongside codes and dates.

    • Sacroiliac/hip injection CPTs mapped to hip arthroplasty codes (eg, 27125, 27130, 27132, 27134) are listed with effective dates.
    • Total knee and related arthroplasty/arthroscopy CPTs (eg, 29860–29883, 29874–29881) are listed and require authorization per the code list.
    Note

    CPT code mappings and notes

    The document provides CPT code mappings and notes showing mapped equivalents or descriptive titles and effective dates; providers should use these mappings and the dates to determine authorization applicability (examples include arthroscopy/arthroplasty mappings such as 29828, 29860 and other mapped entries).

    • Many codes are shown with mapping notes and effective dates; use the list to identify mapped equivalents when submitting requests.
    • Check the effective date shown next to a code to determine when the requirement applies.
    Prior Authorization

    CPT code listing (partial)

    This excerpt includes many CPT procedure codes paired with effective/change dates that indicate prior authorization or notification requirements; providers must reference the listed codes and dates when requesting authorization.

    • Examples in this fragment include 43210 (1/2/2020 = 4/1/2021), 43290 (1/2/2020 = 5/1/2023), and other CPT lines with dates.
    • Use the payer’s secure provider portal and the code list to submit requests for these CPTs.
    Prior Authorization

    Epidural/interlaminar injections — prior auth/notification entries

    Epidural and interlaminar injection procedures (CPTs 62321, 62322, 62323) and additional interlaminar injection entries (62324–62327) are listed with imaging-guidance distinctions and effective dates; these injection services require prior authorization or notification as shown.

    • 62321 — interlaminar epidural/subarachnoid injection, cervical or thoracic; with imaging guidance (2 = 10/1/2018).
    • 62322 — interlaminar epidural/subarachnoid injection, lumbar or sacral; without imaging guidance (2 = 1/2/2020).
    • 62323 — interlaminar epidural/subarachnoid injection, lumbar or sacral; with imaging guidance (2 = 1/2/2020).
    • 62324–62327 — injection(s) including indwelling catheter placement and continuous infusion entries with dates (10/1/2018).
    Prior Authorization

    Intrathecal/epidural catheter and pump procedures

    Intrathecal/epidural catheter and pump implantation, revision, replacement and reservoir procedures (CPTs 62350–62362) are on the list and require prior authorization or notification; effective dates are shown alongside each code.

    • 62350–62351 — implantation/revision/repositioning of tunneled intrathecal or epidural catheter (10/1/2018).
    • 62360–62362 — implantation/replacement of intrathecal/epidural infusion devices and pumps (10/1/2018).
    Prior Authorization

    Spinal decompression and laminectomy

    Spinal decompression, laminectomy, laminotomy and related decompressive procedures (CPTs 62380, 63001, 63003, 63005, 63012, 63015, 63017, etc.) are listed with effective dates and require prior authorization/notification per the payer list.

    • 62380 — endoscopic decompression of spinal cord/nerve root(s), lumbar (10/1/2018).
    • 63001, 63003, 63005, 63012, 63015, 63017 — laminectomy and decompression CPTs with dates indicating authorization requirement.
    Prior Authorization

    Laminotomy/laminoplasty and reexploration

    Laminotomy/laminoplasty and re-exploration procedure codes (CPTs 63020, 63030, 63035, 63042–63050, 63082, etc.) are included on the prior authorization/notification list and have effective dates; providers must reference these when requesting authorization.

    • 63020–63035 — laminotomy/hemilaminectomy entries with effective dates (10/1/2018).
    • 63042–63050, 63082 — reexploration and additional laminotomy/laminoplasty codes with dates (10/1/2018).
    Prior Authorization

    Neurostimulation and related injections

    Neurostimulation services and related injection procedures (examples: CPTs 63650, 63685, 64454, 64479–64484) are listed on the prior authorization/notification list; imaging-guidance distinctions and effective dates are shown.

    • 63650 — percutaneous implantation of neurostimulator electrode array, epidural (10/1/2018).
    • 63685 — laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural (10/1/2018).
    • 64454 — genicular nerve injections with imaging guidance, effective 1/1/2023; 64479–64484 — transforaminal epidural injections with guidance (10/1/2018).
    Prior Authorization

    Peripheral and cranial nerve injections and stimulators

    Peripheral and cranial nerve injection and stimulator procedures (CPTs 64490–64590 series including paravertebral facet injections, stellate ganglion, sacral nerve, cranial nerve neurostimulator implantation and peripheral pulse generator procedures) are included on the list and require authorization/notification as indicated.

    • 64490–64495 — paravertebral facet/paraspinal injections with imaging guidance (10/1/2018).
    • 64510, 64520, 64553, 64561, 64568, 64581–64583, 64590 — peripheral and cranial nerve stimulator and generator implantation/replacement codes with dates.
    Prior Authorization

    Neurolytic and radiofrequency ablation procedures

    Neurolytic and radiofrequency ablation procedures including basivertebral nerve destruction (CPTs 64624–64636 and related entries) are listed with effective dates; providers must obtain prior authorization/notification for these services per the code list.

    • 64624 — neurolytic destruction, genicular nerve branches (1/1/2023).
    • 64628–64629 — thermal destruction of intraosseous basivertebral nerve including imaging guidance (1/1/2023).
    • 64633–64636 — neurolytic ablation of facet joint nerves with imaging guidance (10/1/2018).
    Prior Authorization

    Oculoplastic and otoplasty / ENT and hearing device procedures

    Oculoplastic, otoplasty, ENT and osseointegrated hearing device procedures (examples: CPTs 67900–67909, 69300, 69705–69730) are included on the list with effective dates and require prior authorization/notification per the payer’s list.

    • 67900–67909 — oculoplastic procedures listed with dates (1/2/2020).
    • 69705–69706 — nasopharyngoscopy with Eustachian tube balloon dilation (5/1/2023).
    • 69710–69730 — osseointegrated implant and replacement codes listed with dates (2022–2023).
    Prior Authorization

    CT and MRI imaging procedures

    A wide range of CT and MRI imaging CPT codes (head/brain, orbit/face/neck, CT angiography, thorax, spine and extremity MR/CT codes) are on the prior authorization/notification list; providers must reference the list and effective dates when seeking authorizations.

    • Examples include CT head codes 70450–70470 and MRI brain codes 70551, 70553–70555 (effective dates 8/1/2018).
    • CT/MR extremity and abdominal/pelvis codes (eg, 73702, 73706, 74150–74178) are listed with dates and mapping notes.
    • Cardiac MRI CPTs (75559–75577 series) are listed with effective dates (9/1/2018 and others).
    Prior Authorization

    Imaging CPT codes requiring prior authorization/notification (examples)

    Imaging CPT codes requiring prior authorization/notification include numerous MRI and CT codes mapped in the list (examples: 70551, 70553, 70554, 70555, 71250–71275, 71550–71555). Providers should consult the code list and effective dates when submitting authorization requests.

    • 70551 — MRI brain without contrast (8/1/2018).
    • 70553–70555 — MRI brain with contrast/functional MRI entries (8/1/2018).
    • 71250–71275 and 71550–71555 — CT/MR thorax and chest mappings listed with dates (8/1/2018).
    Prior Authorization

    CT/MR extremity and abdominal CPT codes

    CT and MR extremity and abdominal/pelvic CPT codes (examples: 73700–73725 series for extremities; 74150–74178 series for abdomen/pelvis) are included on the prior authorization/notification list with effective dates; use the list when requesting authorization.

    • 73702, 73706, 73718–73725 — CT/MR lower extremity mappings (8/1/2018).
    • 74150–74178 — CT abdomen/pelvis and angiography mappings (8/1/2018).
    Prior Authorization

    Cardiac MRI CPT codes

    Cardiac MRI and related CPTs (examples: 75559, 75561, 75563, 75571–75574, 75577) are on the list and require prior authorization/notification; effective dates are shown alongside these codes.

    • 75559–75563 — cardiac MRI morphology and function CPTs with effective dates (9/1/2018).
    • 75571–75574, 75577 — other cardiac MR/CT and postprocessing entries listed with dates (9/1/2018; 5/1/2026 for 75577).
    Prior Authorization

    Radiation therapy/medical physics codes

    Radiation oncology delivery/management and medical physics CPT codes (examples: 77334, 77336, 77338, 77370–77373, 77387, 77402, 77407, 77412, 77417, 77423–77427) are included on the prior authorization/notification list; providers must obtain authorization per the payer’s process.

    • 77336 — continuing medical physics consultation, reported per week (effective 10/1/2021).
    • 77371–77373 — stereotactic radiosurgery and SBRT delivery codes (10/1/2021).
    • 77402, 77407, 77412 — radiation treatment delivery level codes with effective dates (10/1/2021).
    Prior Authorization

    Brachytherapy, proton therapy, hyperthermia

    Brachytherapy, proton therapy and hyperthermia CPT codes (examples: 77520–77525 for proton therapy; 77750–77799 series for brachytherapy; 77600–77620 for hyperthermia) are included on the list and require prior authorization/notification as indicated.

    • 77523–77525 — proton treatment delivery (intermediate/complex) listed with dates (9/1/2021).
    • 77600–77620 — hyperthermia therapy CPTs listed (10/1/2021).
    • 77761–77772, 77767–77768 — brachytherapy entries with effective dates (10/1/2021).
    Prior Authorization

    Diagnostic nuclear medicine and radiopharmaceutical codes

    Extensive diagnostic nuclear medicine and radiopharmaceutical CPT codes (examples: 78012–78499, 78600–78816 series, 78709, 78800–78816) are listed and require prior authorization/notification per the payer list; effective dates are shown for many entries.

    • 78012–78020 — thyroid uptake and imaging codes (effective 8/1/2018).
    • 78071–78075, 78102–78104 — parathyroid and bone marrow imaging series (8/1/2018).
    • 78800–78816 — radiopharmaceutical localization and PET/SPECT imaging codes (8/1/2018; 4/1/2020 for select PET codes).
    Prior Authorization

    Prior authorization/notification requirement listing (partial)

    This excerpt enumerates imaging, genetic and laboratory procedure codes that are subject to the payer’s prior authorization/notification requirements; providers must reference the list and effective dates when requesting authorization or submitting notifications.

    • The listing includes imaging CPTs (eg, 78709, 78800–78804, 78811–78816) and genomic/genetic test codes.
    • Providers must use the payer’s code list to determine which services require prior authorization/notification and the effective date applicable.
    Prior Authorization

    Genomic/molecular oncology panels

    Genomic and molecular oncology panels (examples: CPTs 81451, 81455, 81456, 81458, 81459, 81462–81464) are listed and require prior authorization/notification; many entries include panel gene-count groupings and effective/revision dates.

    • 81451 — hematolymphoid neoplasm panel, 5–50 genes, RNA analysis (effective 7/1/2023).
    • 81455–81456 — solid organ/hematolymphoid panels with ≥51 genes (effective 9/1/2021 and 7/1/2023 respectively).
    • Entries specify panel sizes (eg, 5–50 genes, ≥51 genes) and effective dates; use the list when requesting authorization.
    Prior Authorization

    Oncology molecular tests and expression panels

    Oncology molecular tests and gene expression panels (examples: CPTs 81471, 81479, 81493, 81503–81523, 81525–81551) are listed with indications and effective dates; prior authorization/notification is required per the code list.

    • 81471 — duplication/deletion gene analysis for XLID, must include analysis of at least 60 genes (effective 1/1/2023).
    • 81518, 81519, 81520 — breast oncology gene expression profiling entries with effective dates (various 2021–2025 dates).
    • 81560 — IPF 190-gene expression assay listed with dates (1/1/2023 = 5/1/2023).
    Prior Authorization

    Pulmonary disease (IPF) gene expression and related codes

    mRNA gene expression assays for pulmonary disease (IPF) and related CPTs (examples: 81560, 81595, and linked ancillary CPTs 82523, 84999, 86015–86037, 88267–88269, 89250) are listed and require prior authorization/notification per the payer list; effective dates are shown.

    • 81560 — IPF 190-gene expression assay (1/1/2023 = 5/1/2023).
    • 81595 and related lab/test CPTs are cross-listed with effective dates; providers must reference these codes when requesting authorization.
    Prior Authorization

    Category I/III and PLA laboratory codes

    Category I/III and PLA laboratory codes (examples: 0001U, 0003U, 0005U, 0007U, 0008U, 0010U, 0011M/0011U, 0012M, etc.) are included on the list; providers must request prior authorization/notification for these molecular, infectious disease, pharmacologic and transplant-related tests as indicated.

    • 0001U — red blood cell antigen typing DNA, 35 antigens (effective 1/1/2023).
    • 0010U — infectious disease strain typing by whole genome sequencing (effective 1/1/2023).
    • 0011M/0011U, 0012M, 0013M and other M/U codes for oncology and transplant tests have dates and require authorization.
    Prior Authorization

    Code list (partial)

    This excerpt contains a partial code list of laboratory, diagnostic and procedural codes (including proprietary U/T codes and temporary T-codes) that are subject to prior authorization/notification; providers must reference the payer’s full list when submitting authorization or notification requests.

    • Representative U/T codes are included (eg, 0120U, 0247U, 0250U, 0334U) with service descriptions and effective dates.
    • T-code examples (eg, 0335T, 0441T, 0546T) are present; many entries include implementation dates to determine applicability.
    Prior Authorization

    Prior authorization/notification listing (excerpts)

    Excerpts of the prior authorization/notification listing include many U/T proprietary codes for genomic, oncology, obstetrics, and other advanced diagnostics (examples: 0247U, 0250U, 0334U, 0335U); providers must request prior authorization/notify per the listed effective dates and descriptors.

    • 0247U — IBP4/SHBG preterm birth predictive-risk stratification (10/1/2021).
    • 0250U — targeted genomic DNA analysis of 505 genes (effective 7/1/2025).
    • 0334U — oncology targeted genomic analysis of ≥84 genes (1/1/2023).
    Prior Authorization

    Code list – lab and procedure items requiring authorization/notification

    The payer’s code list identifies lab and procedure items requiring authorization/notification, including numerous U-codes and T-codes; providers must consult the list and include effective dates when submitting authorization requests.

    • Examples include 0247U (IBP4/SHBG), 0250U (505-gene panel), and 0334U (84+ gene panel) with effective dates.
    • Providers should reference the code descriptor and effective date from the list when preparing prior authorization requests.
    Prior Authorization

    Code list excerpt — provider notification/prior auth

    The document provides a provider-oriented code list excerpt that includes procedure and laboratory codes with descriptors and effective dates; when seeking prior authorization or submitting notifications, providers must reference these entries.

    • Representative entries include 0334U (84+ gene oncology panel), 0335T (sinus tarsi implant insertion), and 0441T–0444T T-code examples with dates.
    • Many entries show the effective date for the authorization/notification requirement; use that date to determine applicability.
    Prior Authorization

    T-code list (excerpt)

    A partial T-code list (examples: 0546T, 0552T, 0559T, 0565T, 0566T, 0569T, 0570T, 0632T–0635T, 0650T–0655T) is included; these temporary/proprietary CPT T-codes require prior authorization or notification per the payer’s list and effective dates.

    • 0546T — intraoperative radiofrequency spectroscopy margin assessment at partial mastectomy (1/1/2023).
    • 0565T/0566T — autologous cellular implant for knee osteoarthritis (1/1/2023).
    • 0633T–0635T, 0650T–0655T — CT breast and other T-code examples with effective dates (1/1/2023; earlier mapping dates noted).
    Note
    Note

    Effective date guidance (implicit)

    Many entries in the code lists include effective or implementation dates indicating when the prior authorization/notification requirement began or changed; providers must use these dates to determine whether a code is currently subject to authorization/notification.

    • Effective dates are shown alongside most CPT/U/T entries (examples: 8/1/2018, 10/1/2018, 1/1/2023, 7/1/2025).
    • Check the effective date next to a code on the list to determine applicability before submitting an authorization or notification.
    Note

    Definitions and Terminology

    Prior authorization — definition & key notes
    Definition of Prior AuthorizationPrior authorization is an approval process to determine medical necessity before providing certain services; not a guarantee of payment
    Verification requirementReimbursement of authorized services is dependent on eligibility, benefit limitations/exclusions and plan benefits; verify benefits via member booklet or customer service
    Submission pathwayElectronic preauthorization requests are submitted via the Baylor Scott & White Health Plan secure provider portal; call the number on the member's ID card for access
    Notification — definition & purpose
    Definition of NotificationA non-authorization notice requested to assist with discharge planning, care coordination, and case management
    PurposeNotifications are not authorizations but help the plan coordinate care and discharge planning
    When to notifyCertain services listed on the prior authorization/notification list require notification rather than prior authorization; see code list for specifics
    Prior authorization / notification list — definition
    What the list isA compiled list of CPT/HCPCS/T/U codes that require prior authorization or notification per the payer's policy
    Content typesIncludes procedural CPTs, imaging codes, radiation/physics codes, and genomic/molecular test codes (Category I/III, PLA, U/T codes)
    Use in workflowsProviders must reference the list entries (and their effective dates) when determining whether to submit PA or notification
    CPT code mapping / notification list — definition & use
    CPT code mapping entriesSegments show CPT procedure codes with mapped descriptive titles or equivalent procedure mappings and effective dates (e.g., 29828, 29860 series; MRI mappings in chunk 92)
    Mapping purposeMappings indicate equivalent or related procedures for PA/notification application and may include date annotations
    Providers should consult mappingUse the mapping lines to confirm which code/reporting scenarios require PA or notification based on the listed effective date
    Prior authorization / notification list entry — definition
    Code + date entry formatMany list entries appear as a CPT code line paired with an effective or revised date (example: 43210, 1/2/2020 = 4/1/2021)
    InterpretationThe paired date(s) indicate when the prior authorization/notification requirement was implemented or changed
    Provider actionProviders should reference the date shown to determine applicability for the member's date of service
    Definition: 'with imaging guidance'
    Imaging with guidanceWhen codes explicitly indicate 'with imaging guidance', they refer to procedures performed using fluoroscopy or CT guidance (e.g., epidural injections with/without imaging guidance in chunks 72/73)
    Example codes62321, 62323 specify interlaminar epidural/subarachnoid injections with imaging guidance (chunk 72)
    Implication for PA/notificationPresence of imaging guidance in code descriptors is shown on the list and informs authorization applicability
    Indwelling catheter / pump — definition & examples
    Indwelling catheter / pump proceduresCodes for implantation or management of tunneled intrathecal or epidural catheters and infusion pumps are listed (e.g., 62350 series for implantation/revision of tunneled intrathecal/epidural catheter)
    Examples62350 = implantation/revision/repositioning of tunneled intrathecal or epidural catheter for long-term medication administration
    PA implicationThese device and pump procedures are included on the PA/notification list and have effective dates noted
    Code mapping — definition & guidance
    Code mapping can show equivalentsMappings often show equivalent or related procedures (for example, MRI brain codes mapped to CT cervical spine equivalents) and include effective dates
    Use-caseUse mapping lines to find alternate codes or related procedures that may trigger PA/notification
    Example mapping locationsSee MRI/CT mapping examples in chunks 92 and arthroscopy mappings in chunk 36
    Definition: CPT 77336
    77336 description77336 = Continuing medical physics consultation, including assessment of treatment parameters, QA of dose delivery, and review of patient treatment documentation; reported per week of therapy
    Reporting frequencyListed as a weekly (per week) consultation code on the PA list with effective date annotations
    PA listingIncluded in the radiation therapy/medical physics codes section of the PA/notification list (chunk 109)
    Definition: 77520-77525 (proton treatment delivery)
    Proton treatment delivery codes77520-77525 series listed for proton treatment delivery (simple, intermediate, complex) with effective date entries
    Examples of effective dates77523 = intermediate (9/1/2021); 77525 = complex (9/1/2021)
    ContextThese codes are included in the radiation/therapy section of the PA list and have date annotations to determine PA applicability
    Commercial Prior Authorization / Notification List — definition
    Commercial Prior Authorization/Notification List (title)The document is the payer's compiled prior authorization and notification code list used by Baylor Scott & White Health Plan
    Scope of entriesIncludes procedural CPTs, imaging, radiation therapy/physics, nuclear medicine, genetic/molecular assays (Category I/III/PLA/U/T codes) with descriptions and effective dates
    Provider action requiredProviders must reference this list and the secure provider portal when submitting PAs or notifications
    Genomic panel — definition & examples
    Genomic panel definitionGenomic sequence analysis panels are listed by gene-count ranges (eg, 5–50 genes, 51+ genes) and by intended clinical use (hematolymphoid, solid organ neoplasms)
    Panel content typesPanels may interrogate sequence variants, copy number variants, rearrangements, RNA/mRNA expression levels, and tumor mutation burden depending on code
    Example codes81445 = solid organ neoplasm panel, 5–50 genes; 81455/81456 = 51+ gene panels for solid organ or hematolymphoid neoplasms
    Genomic sequence analysis panel (alternate descriptor)
    Alternate genomic panel descriptorGenomic sequence analysis panel entries may specify DNA analysis, RNA analysis, or combined DNA/RNA analysis and note gene-count thresholds
    Clinical categoriesPanels are designated for solid organ neoplasms, hematolymphoid disorders, hereditary conditions, or other specified indications
    Example code notes81451 = hematolymphoid neoplasm panel (5–50 genes), RNA analysis; 81455 = >=51 genes, DNA or combined DNA/RNA analysis
    IPF 190‑gene expression assay — definition & codes
    IPF 190‑gene assay81560 / 81595 = mRNA gene expression analysis of 190 genes for idiopathic pulmonary fibrosis (IPF), reported as categorical result (eg, high probability of UIP)
    Specimen and methodListed as utilizing transbronchial biopsies (81560) and transbronchial biopsies or related specimens per code descriptors
    Cross-listed codesThese IPF gene expression codes are cross-referenced with other CPT/ancillary codes in the list (see chunk 149)
    U/T/M codes — definition
    U/T/M code conceptU/T/M codes are proprietary temporary or emerging-technology codes used to identify new laboratory and procedural services (examples: 0010U, 0054T, 0064U)
    PurposeThey identify tests/procedures not yet represented by standard CPT/HCPCS codes or requiring temporary tracking
    Presence in listMultiple U- and T-codes are included with descriptions and effective dates for PA/notification purposes
    U-code / T-code — definitions
    U-code definitionU-codes in the list denote proprietary laboratory and service codes used to identify specific tests and assays (eg, 0250U = 505-gene targeted genomic panel)
    T-code definitionT-codes denote temporary CPT-category procedure codes for new or evolving services (examples scattered through the list, e.g., 0335T, 0441T)
    In-list usageBoth U- and T-codes include service descriptors and effective dates to indicate PA/notification requirements
    Category I unlisted / proprietary lab code — definition
    Category I unlisted/proprietary lab code usageSome entries use a Category I/III/PLA-style descriptor for novel molecular or diagnostic tests (listed alongside U/T codes) to document PA requirements
    Example locationsSee U-code/PLA groupings in chunks 162–172 and 216–234 for Category I/III and PLA examples
    Provider actionWhen encountering unlisted or proprietary lab codes, providers should reference the list description and effective date when requesting PA
    T-code — definition & examples
    T-code (temporary CPT) definitionT-codes are temporary CPT-category codes for emerging procedures/services and are listed with descriptors and effective dates on the PA/notification list
    Examples0441T–0444T (cryoablation entries) and 0546T (intraoperative margin assessment) are shown with 1/1/2023 effective dates in the list
    PA implicationT-codes on the list require that providers reference the PA/notification requirement and effective date when submitting authorizations
    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyCommercial Prior Authorization / Notification List (partial)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionSubmit electronic preauthorization requests via the secure provider portal and verify member benefits prior to providing listed services.
    SourceLink
    On This Page
    Coverage Criteria and Code ListingsCode Tables and Coding DetailsProvider Instructions and Required ActionsDefinitions and Terminology